ALDX
Price
$4.90
Change
-$0.11 (-2.20%)
Updated
Dec 13, 04:59 PM (EDT)
82 days until earnings call
TGTX
Price
$32.05
Change
+$1.36 (+4.43%)
Updated
Dec 13, 04:59 PM (EDT)
80 days until earnings call
Ad is loading...

ALDX vs TGTX

Header iconALDX vs TGTX Comparison
Open Charts ALDX vs TGTXBanner chart's image
Aldeyra Therapeutics
Price$4.90
Change-$0.11 (-2.20%)
Volume$3.29K
CapitalizationN/A
TG Therapeutics
Price$32.05
Change+$1.36 (+4.43%)
Volume$54.6K
CapitalizationN/A
ALDX vs TGTX Comparison Chart
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. TGTX commentary
Dec 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Hold and TGTX is a Hold.

COMPARISON
Comparison
Dec 14, 2024
Stock price -- (ALDX: $4.90 vs. TGTX: $32.02)
Brand notoriety: ALDX and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 64% vs. TGTX: 66%
Market capitalization -- ALDX: $291.79M vs. TGTX: $4.98B
ALDX [@Biotechnology] is valued at $291.79M. TGTX’s [@Biotechnology] market capitalization is $4.98B. The market cap for tickers in the [@Biotechnology] industry ranges from $489.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileTGTX’s FA Score has 0 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • TGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, ALDX is a better buy in the long-term than TGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 4 TA indicator(s) are bullish while TGTX’s TA Score has 4 bullish TA indicator(s).

  • ALDX’s TA Score: 4 bullish, 5 bearish.
  • TGTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TGTX is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а -6.13% price change this week, while TGTX (@Biotechnology) price change was -5.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.93%. For the same industry, the average monthly price growth was -4.54%, and the average quarterly price growth was +6.84%.

Reported Earning Dates

ALDX is expected to report earnings on Mar 06, 2025.

TGTX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-3.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($4.98B) has a higher market cap than ALDX($292M). TGTX YTD gains are higher at: 87.471 vs. ALDX (39.601). TGTX has higher annual earnings (EBITDA): 5.82M vs. ALDX (-42.57M). TGTX has more cash in the bank: 341M vs. ALDX (113M). ALDX has less debt than TGTX: ALDX (15.6M) vs TGTX (254M). TGTX has higher revenues than ALDX: TGTX (265M) vs ALDX (0).
ALDXTGTXALDX / TGTX
Capitalization292M4.98B6%
EBITDA-42.57M5.82M-731%
Gain YTD39.60187.47145%
P/E RatioN/A39.56-
Revenue0265M-
Total Cash113M341M33%
Total Debt15.6M254M6%
FUNDAMENTALS RATINGS
ALDX vs TGTX: Fundamental Ratings
ALDX
TGTX
OUTLOOK RATING
1..100
1772
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
85
Overvalued
PROFIT vs RISK RATING
1..100
10057
SMR RATING
1..100
9791
PRICE GROWTH RATING
1..100
4437
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALDX's Valuation (42) in the Biotechnology industry is somewhat better than the same rating for TGTX (85). This means that ALDX’s stock grew somewhat faster than TGTX’s over the last 12 months.

TGTX's Profit vs Risk Rating (57) in the Biotechnology industry is somewhat better than the same rating for ALDX (100). This means that TGTX’s stock grew somewhat faster than ALDX’s over the last 12 months.

TGTX's SMR Rating (91) in the Biotechnology industry is in the same range as ALDX (97). This means that TGTX’s stock grew similarly to ALDX’s over the last 12 months.

TGTX's Price Growth Rating (37) in the Biotechnology industry is in the same range as ALDX (44). This means that TGTX’s stock grew similarly to ALDX’s over the last 12 months.

TGTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ALDX (100). This means that TGTX’s stock grew similarly to ALDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXTGTX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 23 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EMMF27.500.12
+0.45%
WisdomTree Emerging Markets Mltfctr
IVVB31.540.01
+0.02%
iShares Large Cap Deep Buffer ETF
CFO71.41-0.34
-0.47%
VictoryShares US 500 Enh Vol Wtd ETF
MLPX60.91-0.39
-0.64%
Global X MLP & Energy Infrastructure ETF
BWEB60.81-0.47
-0.77%
Bitwise Web3 ETF

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with CANF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-2.20%
CANF - ALDX
46%
Loosely correlated
-3.07%
FOLD - ALDX
46%
Loosely correlated
-7.78%
CRSP - ALDX
41%
Loosely correlated
-3.57%
ATAI - ALDX
41%
Loosely correlated
-2.16%
NTLA - ALDX
41%
Loosely correlated
-4.87%
More

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with EDIT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
+4.33%
EDIT - TGTX
45%
Loosely correlated
-23.81%
ALT - TGTX
40%
Loosely correlated
+5.12%
NTLA - TGTX
38%
Loosely correlated
-4.87%
CRNX - TGTX
37%
Loosely correlated
-3.52%
ARRY - TGTX
36%
Loosely correlated
+0.36%
More